[1]
Lei, L. and Weidong, Z. 2022. Small molecule TKI inhibitors affect the development of non-small cell carcinoma through HIPPO/YAP/PD-L1. Cellular and Molecular Biology. 67, 5 (Feb. 2022), 117–122. DOI:https://doi.org/10.14715/cmb/2021.67.5.16.